1. Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer. Issue 4 (5th January 2023) Authors: Andrikopoulou, Angeliki; Liontos, Michalis; Skafida, Efthymia; Koutsoukos, Konstantinos; Apostolidou, Kleoniki; Kaparelou, Maria; Rouvalis, Angeliki; Bletsa, Garyfallia; Dimopoulos, Meletios-Athanasios; Zagouri, Flora Journal: International journal of gynecological cancer Issue: Volume 33:Issue 4(2023) Page Start: 571 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗